Myasthenia gravis, Guillain-Barre syndrome is an autoimmune disorder

Myasthenia Gravis and Guillain-Barre Syndrome: Impaired Spontaneous Breathing as the Best Diagnosis

Myasthenia gravis, often known as Guillain-Barre syndrome, is an autoimmune condition that causes muscle weakening. Yet, when it comes to choosing the best diagnosis, impaired spontaneous breathing is the best choice because it applies to both myasthenia gravis and Guillain-Barre syndrome. It focuses more on the metabolic and internal processes, making it more intrusive and hence better suited for detecting sickness (Moore, & Shepard, 2014). The nurses can also tell if the condition has produced a respiratory failure, such as if the patient’s oxygenation is compromised or has an impaired gas exchange.

Benefits of Impaired Spontaneous Ventilation Diagnosis

Impaired spontaneous ventilation serves the patient’s needs by allowing him or her to undergo numerous therapy to maintain adequate respiration. Similarly, the diagnosis enables the patient to maintain the proper arterial blood gas standards in the body (Misra, Temesgen, Soleiman, Kalyanam, & Kurukumbi, 2017). It also helps in the maintenance of adequate ventilation to ensure that the patient recovers from the muscles weaknesses. For instance using mechanical ventilation acts as a lifesaving therapy helping the patients which respiratory failure that causes the weakening of the muscles. The diagnosis ensures adequate ventilation for oxygen consumption and the production of carbon IV oxide preventing such weaknesses from happening from the lungs (Moore, & Shepard, 2014).

Importance of Urgent Intervention and Effective Therapy Management

To ensure that the patients reach the outcome of the diagnosis, urgent intervention should be put into consideration. First, the nurses should monitor the severe signs such as the breathing sounds of the patient, temperature, the consistency and amount of sputum as well as overseeing the hydration of the patient to identify the appropriate medication. In addition, suitable measures should be implemented to promote effective therapy management and education, as it will reinforce the importance of follow-up care for patients (Misra, Temesgen, Soleiman, Kalyanam, & Kurukumbi, 2017).

References

Misra, I., Temesgen, F., Soleiman, N., Kalyanam, J., & Kurukumbi, M. (2017). Myasthenia Gravis Presenting Like Guillain-Barré Syndrome. Retrieved 25 September 2017, from

Moore, A.S. & Shepard, L.H. (2014). Myasthenia gravis vs. guillain-barré syndrome what is the difference? Nursing Made Incredibly Easy! 12 (4). 21-30.